Sanofi Aventis, SA secures contract for Pharmaceutical products Supply of medicines for human use whose active ingredients are ALEMTUZUMAB CLADRIBINA OCRELIZUMAB PONESIMOD AND UBLITUXIMAB destined for centers within the Valencian Public Health field

Spain, May 8 -- Spain based Sanofi Aventis, SA has secured contract from Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad for Pharmaceutical products Supply of medicines for human use whose active ingredients are ALEMTUZUMAB CLADRIBINA OCRELIZUMAB PONESIMOD AND UBLITUXIMAB destined for centers within the Valencian Public Health field. The value of the contract is worth 616250 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....